500
Views
0
CrossRef citations to date
0
Altmetric
Immunotherapy - Cancer

The functionality of a therapeutic antibody candidate restored by a single mutation from proline to threonine in the variable region

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon show all
Article: 2279867 | Received 13 Jul 2023, Accepted 02 Nov 2023, Published online: 27 Nov 2023

References

  • Davenport AP, Hyndman KA, Dhaun N, Southan C, Kohan DE, Pollock JS, Pollock DM, Webb DJ, Maguire JJ. Endothelin. Pharmacol Rev [Internet]. 2016;68(2):357–9. doi:10.1124/pr.115.011833.
  • Rosanò L, Bagnato A. Endothelin therapeutics in cancer: where are we? Am J Physiol Regul Integr Comp Physiol [Internet]. 2016;310(6):R469–75. doi:10.1152/ajpregu.00532.2015.
  • D’Orléans-Juste P, Akide Ndunge OB, Desbiens L, Tanowitz HB, Desruisseaux MS. Endothelins in inflammatory neurological diseases. Pharmacol Ther [Internet]. 2019;194:145–60. doi:10.1016/j.pharmthera.2018.10.001.
  • Weigert A, Zheng X, Nenzel A, Turkowski K, Günther S, Strack E, Sirait-Fischer E, Elwakeel E, Kur IM, Nikam VS, et al. Fibrocytes boost tumor-supportive phenotypic switches in the lung cancer niche via the endothelin system. Nat Commun [Internet]. 2022;13(1):6078. doi:10.1038/s41467-022-33458-8.
  • Barton M, Yanagisawa ME. 30 years from discovery to therapy. Hypertension [Internet]. 2019;74(6):1232–65. doi:10.1161/HYPERTENSIONAHA.119.12105.
  • Clozel M, Breu V, Burri K, Cassal J-M, Fischli W, Gray GA, Hirth G, Müller M, Neidhart W, Ramuz H. Pathophysiological role of endothelin revealed by the first orally active endothelin receptor antagonist. Nature [Internet]. 1993;365(6448):759. doi:10.1038/365759a0.
  • Kappes L, Amer RL, Sommerlatte S, Bashir G, Plattfaut C, Gieseler F, Gemoll T, Busch H, Altahrawi A, Al-Sbiei A, et al. Ambrisentan, an endothelin receptor type A-selective antagonist, inhibits cancer cell migration, invasion, and metastasis. Sci Rep [Internet]. 2020;10(1):15931. doi:10.1038/s41598-020-72960-1.
  • Tocci P, Roman C, Sestito R, Di Castro V, Sacconi A, Molineris I, Paolini F, Carosi M, Tonon G, Blandino G, et al. Targeting tumor-stroma communication by blocking endothelin-1 receptors sensitizes high-grade serous ovarian cancer to PARP inhibition. Cell Death Dis [Internet]. 2023;14(1):1–14. doi:10.1038/s41419-022-05538-6.
  • Allard B, Wijkhuisen A, Borrull A, Deshayes F, Priam F, Lamourette P, Ducancel F, Boquet D, Couraud J-Y. Generation and characterization of rendomab-B1, a monoclonal antibody displaying potent and specific antagonism of the human endothelin B receptor. MAbs [Internet]. 2013;5(1):56–69. doi:10.4161/mabs.22696.
  • Borrull A, Allard B, Wijkhuisen A, Herbet A, Lamourette P, Birouk W, Leiber D, Tanfin Z, Ducancel F, Boquet D, et al. Rendomab B4, a monoclonal antibody that discriminates the human endothelin B receptor of melanoma cells and inhibits their migration. MAbs [Internet]. 2016;8(7):1371–85. doi:10.1080/19420862.2016.1208865.
  • Herbet A, Costa N, Leventoux N, Mabondzo A, Couraud J-Y, Borull A, Hugnot J-P, Boquet D. Antibodies targeting human endothelin-1 receptors reveal different conformational states in cancer cells. Physiol Res [Internet]. 2018;67:257–64. doi:10.33549/physiolres.933848.
  • Hautiere M, Vivier D, Pineau D, Denis C, Kereselidze D, Herbet A, Costa N, Goncalves V, Selingue E, Larrat B, et al. ImmunoPET imaging–based pharmacokinetic profiles of an antibody and its Fab targeting endothelin a receptors on glioblastoma stem cells in a preclinical orthotopic model. Eur J Nucl Med Mol Imaging [Internet]. 2023;50(11):3192–201. doi:10.1007/s00259-023-06268-3.
  • Boquet D, Ducancel F, Herbet A, Costa N, Hugnot J-P. Antibody directed against the endothelin receptor beta sub-type. 2017; WO2017/220739.
  • Lejeune M, Köse MC, Jassin M, Gou M-J, Herbet A, Duray E, Cobraiville G, Foguenne J, Boquet D, Gothot A, et al. Integrative analysis of proteomics and transcriptomics reveals endothelin receptor B as novel single target and identifies New combinatorial targets for multiple myeloma. HemaSphere. [Internet]. 2023;7(7): e901. doi:10.1097/HS9.0000000000000901
  • Brochet X, Lefranc M-P, Giudicelli V. IMGT/V-QUEST: the highly customized and integrated system for IG and TR standardized V-J and V-D-J sequence analysis. Nucleic Acids Res. [Internet]. 2008;36:W503–8. doi:10.1093/nar/gkn316.
  • Congdon EE, Chukwu JE, Shamir DB, Deng J, Ujla D, Sait HBR, Neubert TA, Kong X-P, Sigurdsson EM. Tau antibody chimerization alters its charge and binding, thereby reducing its cellular uptake and efficacy. EBioMedicine. 2019;42:157–73. doi:10.1016/j.ebiom.2019.03.033.
  • Monnet C, Bettsworth F, Stura EA, M-HL D, Ménez R, Derrien L, Zinn-Justin S, Gilquin B, Sibaı̈ G, Battail-Poirot N, et al. Highly specific anti-estradiol antibodies: structural characterisation and binding diversity11Edited by I. A. Wilson. J Mol Biol [Internet]. 2002;315(4):699–712. doi:10.1006/jmbi.2001.5284.
  • Oyama H, Kiguchi Y, Morita I, Yamamoto C, Higashi Y, Taguchi M, Tagawa T, Enami Y, Takamine Y, Hasegawa H, et al. Seeking high-priority mutations enabling successful antibody-breeding: systematic analysis of a mutant that gained over 100-fold enhanced affinity. Sci Rep [Internet]. 2020;10(1):4807. doi:10.1038/s41598-020-61529-7.
  • Masiero A, Nelly L, Marianne G, Christophe S, Florian L, Ronan C, Claire B, Cornelia Z, Grégoire B, Eric L, et al. The impact of proline isomerization on antigen binding and the analytical profile of a trispecific anti-HIV antibody. MAbs [Internet]. 2020;12(1):1698128. doi:10.1080/19420862.2019.1698128.
  • Shinoda K, Fujitani H. Initiation of prolyl cis-trans isomerisation in the CDR-H3 loop of an antibody in response to antigen binding. Sci Rep [Internet]. 2017;7(1):16964. doi:10.1038/s41598-017-16766-8.
  • Alderson TR, Lee JH, Charlier C, Ying J, Bax A. Propensity for cis-proline formation in unfolded proteins. Chem Bio Chem [Internet]. 2018;19(1):37–42. doi:10.1002/cbic.201700548.
  • Essono S, Clément G, Padiolleau-Lefevre S, Créminon C, Grassi J, Boquet D. Peptide mass-assisted antibody cloning strategy for accurate characterization of potential therapeutic monoclonal antibodies against neurodegenerative diseases. Protein Eng Des Sel [Internet]. 2010;23(4):203–10. doi:10.1093/protein/gzp071.
  • Allard B, Priam F, Deshayes F, Ducancel F, Boquet D, Wijkhuisen A, Couraud J-Y. Electroporation-aided DNA immunization generates polyclonal antibodies against the native conformation of human endothelin B receptor. DNA Cell Biol [Internet]. 2011;30(9):727–37. doi:10.1089/dna.2011.1239.
  • Vogt G, Woell S, Argos P. Protein thermal stability, hydrogen bonds, and ion pairs11Edited by F. E. Cohen. J Mol Biol [Internet]. 1997;269(4):631–43. doi:10.1006/jmbi.1997.1042.
  • Lyskov S, Chou F-C, Conchúir SÓ, Der BS, Drew K, Kuroda D, Xu J, Weitzner BD, Renfrew PD, Sripakdeevong P, et al. Serverification of molecular modeling applications: the Rosetta online server that includes everyone (ROSIE). PLOS ONE [Internet]. 2013;8(5):e63906. doi:10.1371/journal.pone.0063906.
  • Williams CJ, Headd JJ, Moriarty NW, Prisant MG, Videau LL, Deis LN, Verma V, Keedy DA, Hintze BJ, Chen VB, et al. MolProbity: more and better reference data for improved all-atom structure validation. Protein Sci [Internet]. 2018;27(1):293–315. https://onlinelibrary.wiley.com/doi/abs/10.1002/pro.3330.
  • Waterhouse A, Bertoni M, Bienert S, Studer G, Tauriello G, Gumienny R, Heer FT, de Beer TAP, Rempfer C, Bordoli L, et al. SWISS-MODEL: homology modelling of protein structures and complexes. Nucleic Acids Res [Internet]. 2018;46(W1):W296–303. doi:10.1093/nar/gky427.
  • Schrödinger LLC The PyMOL molecular graphics system, version 1.8; 2015.
  • Contributors to Amber [Internet]. https://ambermd.org/contributors.html.
  • Maier JA, Martinez C, Kasavajhala K, Wickstrom L, Hauser KE, Simmerling C. ff14SB: improving the accuracy of protein side chain and backbone parameters from ff99SB. J Chem Theory Comput [Internet]. 2015;11(8):3696–713. doi:10.1021/acs.jctc.5b00255.
  • Grant BJ, Rodrigues APC, ElSawy KM, McCammon JA, Caves LSD. Bio3d: an R package for the comparative analysis of protein structures. Bioinformatics [Internet]. 2006;22(21):2695–6. doi:10.1093/bioinformatics/btl461.